
|Videos|October 15, 2015
Dr. S Yousuf Zafar Talks About BMI and Survival Rates in Colorectal Cancer Patients
Dr. S. Yousuf Zafar talks about the association between the body mass index of patients who are starting treatment for colorectal cancer and both the progression free survival and overall survival.
Advertisement
S. Yousuf Zafar, MD, Associate Professor of Medicine at Duke Cancer Institute, talks about the association between the body mass index (BMI) of patients who are starting treatment for colorectal cancer and both the progression free survival (PFS) and overall survival (OS).
Zafar says that while there was no link to be drawn between PFS and BMI in those patients, there was a connection between higher BMI and a better OS rate.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
2
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
3
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
4
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
5



































